Projects

RNDr. Petra Belvončíková, PhD.

National

Current
  • Orchestration of tumor and immune microenvironment in renal cell carcinoma and significance of tumor organoids in predicting therapy response
    Program: SRDA
    Duration: 1. 7. 2024 – 30. 6. 2028
  • Regulation of hypoxic signalling in renal carcinoma with focus on the role of carbonic anhydrase IX in the tumor microenvironment
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
Finished
  • Effects of natural polyphenol and nonsteroidal anti-inflammatory drug combination therapy on the tumor microenvironment
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • The identification of EBHS virus and selected pathogens as possible cause of the European brown hare (Lepus europaeus) population decline in Slovakia
    Program: SRDA
    Duration: 1. 7. 2016 – 31. 12. 2020
  • Imunomodulatory properties of the murine herpesvirus M3 protein and the role of ticks in herpesvirus circulation in nature
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2020
  • The role of vitamin D and interferons type III in gammaherpesvirus oncogenesis
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2019
  • Factors effecting production of cell-free Marek’s disease virus particles in vivo in chicken and in vitro in cell culture
    Program: VEGA
    Duration: 1. 1. 2014 – 31. 12. 2017
  • Characterization of novel motif in M1 protein of influenza A virus and using NS1 deletion mutants in tumor therapy
    Program: SRDA
    Duration: 1. 10. 2013 – 30. 9. 2017
  • Murine gammaherpesvirus a producent of substances exhibiting immunomodulatory and antiproliferative properties
    Program: SRDA
    Duration: 1. 10. 2013 – 30. 9. 2017
  • Murine herpesvirus, a model to study human oncogenic herpesviruses: viral imunomodulator M3 protein and factors important for virus spread among hosts
    Program: VEGA
    Duration: 1. 1. 2013 – 31. 12. 2016
  • Study on induced reactivation of human oncogenic herpesviruses on the model of mice latently infected with
    Program: VEGA
    Duration: 1. 1. 2012 – 31. 12. 2015
  • Effect of hypoxia on replication of herpesviruses.
    Program: VEGA
    Duration: 1. 1. 2011 – 31. 12. 2013
  • Study on novel protein modulator of immune response encoded by Murine gammaherpesvirus
    Program: VEGA
    Duration: 1. 1. 2010 – 31. 12. 2012
Employees